Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-015974
Filing Date
2020-06-10
Accepted
2020-06-10 17:17:39
Documents
1
Period of Report
2020-06-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4151
  Complete submission text file 0000899243-20-015974.txt   5511
Mailing Address GLAXOSMITHKLINE THREE FRANKLIN PLAZA, 1600 VINE STREET PHILADELPHIA PA 19102
Business Address
LOKAY KEVIN G (Reporting) CIK: 0001211256 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39114 | Film No.: 20955482

Mailing Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355
Business Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Issuer) CIK: 0001563577 (see all company filings)

EIN.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations